Novo Nordisk A/S
XMUN:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
XMUN:NOV
|
DK |
|
S
|
Southern Copper Corp
F:PCU
|
US |
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
|
Allbirds Inc
NASDAQ:BIRD
|
US |
|
Capstone Copper Corp
TSX:CS
|
CA |
|
B
|
Brown & Brown Inc
DUS:BTW
|
US |
|
E
|
EssilorLuxottica SA
MIL:EL
|
FR |
|
Vanadi Coffee SA
MAD:VANA
|
ES |
|
P
|
Proteome Sciences PLC
XMUN:PI2
|
UK |
|
A
|
Axon Enterprise Inc
F:TCS
|
US |
|
Vidrala SA
MAD:VID
|
ES |
|
Almirall SA
OTC:LBTSF
|
ES |
|
M
|
Maven Brands Inc
CNSX:MJ
|
CA |
|
M
|
McDonald's Corp
SGO:MCD
|
US |
|
Healthia Ltd
ASX:HLA
|
AU |
|
P
|
Purepoint Uranium Group Inc
F:P5X
|
CA |
|
W
|
Western Digital Corp
BMV:WDC
|
US |
|
Inmode Ltd
F:154
|
IL |
|
Cbrain A/S
CSE:CBRAIN
|
DK |
|
B
|
Barratt Developments P L C
F:3BA
|
UK |
|
Biofrontera Inc
NASDAQ:BFRI
|
US |
|
U
|
Unilever PLC
VSE:ULVR
|
UK |
Bankruptcy Probability
Novo Nordisk A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novo Nordisk A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
37.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novo Nordisk A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novo Nordisk A/S has total debt of 118.9B DKK. This includes both short-term (0 DKK) and long-term (118.9B DKK) debt.
You can find a full breakdown on its Balance Sheet.
